Investors Buy Large Volume of iShares Biotechnology ETF Put Options (NASDAQ:IBB)

iShares Biotechnology ETF (NASDAQ:IBB) was the recipient of some unusual options trading activity on Monday. Investors purchased 66,590 put options on the stock. This is an increase of 1,205% compared to the average daily volume of 5,103 put options.

Hedge Funds Weigh In On iShares Biotechnology ETF

Institutional investors have recently modified their holdings of the stock. Williams Financial LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter worth about $867,000. PVG Asset Management Corp bought a new position in shares of iShares Biotechnology ETF in the second quarter worth about $415,000. Huntington National Bank raised its stake in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after acquiring an additional 160 shares during the last quarter. Concourse Financial Group Securities Inc. raised its stake in shares of iShares Biotechnology ETF by 22.4% in the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after acquiring an additional 120 shares during the last quarter. Finally, Raymond James & Associates raised its stake in shares of iShares Biotechnology ETF by 4.4% in the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after acquiring an additional 7,931 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.5 %

IBB stock traded down $0.67 during trading on Monday, hitting $132.71. 994,555 shares of the stock traded hands, compared to its average volume of 1,450,031. iShares Biotechnology ETF has a one year low of $117.28 and a one year high of $150.57. The company has a 50 day simple moving average of $144.49 and a 200 day simple moving average of $141.78.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.